{"id":227990,"date":"2026-09-02T15:20:26","date_gmt":"2026-09-02T09:50:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=227990"},"modified":"2026-09-02T15:20:27","modified_gmt":"2026-09-02T09:50:27","slug":"sanofi-consumer-healthcare-india-overvalued-or-undervalued","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/","title":{"rendered":"Is Sanofi Consumer Healthcare India Overvalued or Undervalued Right Now?"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Sanofi Consumer Healthcare India CMP Rs 4,092.00 (2 Sep 2026), down 1.11%. PE 35.68 vs industry PE 51.38. ROE 76.46%. 52W range Rs 3,975.00 to Rs 5,357.00.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Sanofi Consumer Healthcare India trades at a price to earnings ratio of 35.68, well below the industry average of 51.38, which points toward undervaluation on a simple multiple basis. The stock&#8217;s 76.46% return on equity and Rs 151.07 book value per share suggest the market may be underpricing the underlying business relative to peers. Whether Sanofi Consumer Healthcare India is overvalued or undervalued right now depends on whether that discount reflects a genuine risk the market has priced in or simply a lack of investor attention. On valuation multiples alone, the stock currently sits below what the broader sector is priced at.<\/p>\n<\/div>\n<p>Is Sanofi Consumer Healthcare India overvalued or undervalued right now is a question worth asking given how its price to earnings ratio compares with the rest of its sector. At the current market price of Rs 4,092.00, the stock trades roughly 23.6% below its 52 week high of Rs 5,357.00 and about 2.9% above its 52 week low of Rs 3,975.00.<\/p>\n<p>Sanofi Consumer Healthcare India&#8217;s share price moved down 1.11% in the latest session to Rs 4,092.00, against a market capitalisation of Rs 9,491 Cr. This article looks at the numbers, the PE ratio, price to book, return on equity, debt levels and recent earnings trends, that determine whether the current price reflects fair value or a stretched multiple, and works through the full Sanofi Consumer Healthcare India overvalued or undervalued picture step by step.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=valn138\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Valuation_Metrics\" title=\"Sanofi Consumer Healthcare India Overvalued or Undervalued: Valuation Metrics\">Sanofi Consumer Healthcare India Overvalued or Undervalued: Valuation Metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Is_Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Based_on_Its_PE_Ratio\" title=\"Is Sanofi Consumer Healthcare India Overvalued or Undervalued Based on Its P\/E Ratio?\">Is Sanofi Consumer Healthcare India Overvalued or Undervalued Based on Its P\/E Ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Sanofi_Consumer_Healthcare_Indias_Financial_Growth_and_Profitability\" title=\"Sanofi Consumer Healthcare India&#8217;s Financial Growth and Profitability\">Sanofi Consumer Healthcare India&#8217;s Financial Growth and Profitability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_The_Case_for_Overvalued\" title=\"Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case for Overvalued\">Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case for Overvalued<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_The_Case_Against_It\" title=\"Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case Against It\">Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case Against It<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Verdict_Is_Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Right_Now\" title=\"Verdict: Is Sanofi Consumer Healthcare India Overvalued or Undervalued Right Now?\">Verdict: Is Sanofi Consumer Healthcare India Overvalued or Undervalued Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_Could_Change_Whether_Sanofi_Consumer_Healthcare_India_Is_Overvalued_or_Undervalued\" title=\"What Could Change Whether Sanofi Consumer Healthcare India Is Overvalued or Undervalued?\">What Could Change Whether Sanofi Consumer Healthcare India Is Overvalued or Undervalued?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_FAQs\" title=\"Sanofi Consumer Healthcare India Overvalued or Undervalued: FAQs\">Sanofi Consumer Healthcare India Overvalued or Undervalued: FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Is_Sanofi_Consumer_Healthcare_India_overvalued_or_undervalued_right_now\" title=\"Is Sanofi Consumer Healthcare India overvalued or undervalued right now?\">Is Sanofi Consumer Healthcare India overvalued or undervalued right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_Sanofi_Consumer_Healthcare_Indias_current_PE_ratio\" title=\"What is Sanofi Consumer Healthcare India&#8217;s current PE ratio?\">What is Sanofi Consumer Healthcare India&#8217;s current PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_Sanofi_Consumer_Healthcare_Indias_return_on_equity\" title=\"What is Sanofi Consumer Healthcare India&#8217;s return on equity?\">What is Sanofi Consumer Healthcare India&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_Sanofi_Consumer_Healthcare_Indias_52_week_high_and_low\" title=\"What is Sanofi Consumer Healthcare India&#8217;s 52 week high and low?\">What is Sanofi Consumer Healthcare India&#8217;s 52 week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Does_Sanofi_Consumer_Healthcare_India_have_high_debt\" title=\"Does Sanofi Consumer Healthcare India have high debt?\">Does Sanofi Consumer Healthcare India have high debt?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_Sanofi_Consumer_Healthcare_Indias_dividend_yield\" title=\"What is Sanofi Consumer Healthcare India&#8217;s dividend yield?\">What is Sanofi Consumer Healthcare India&#8217;s dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#Is_Sanofi_Consumer_Healthcare_India_a_good_stock_to_buy_at_current_levels\" title=\"Is Sanofi Consumer Healthcare India a good stock to buy at current levels?\">Is Sanofi Consumer Healthcare India a good stock to buy at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_Sanofi_Consumer_Healthcare_Indias_price_to_book_ratio\" title=\"What is Sanofi Consumer Healthcare India&#8217;s price to book ratio?\">What is Sanofi Consumer Healthcare India&#8217;s price to book ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-overvalued-or-undervalued\/#What_is_the_simplest_way_to_summarise_Sanofi_Consumer_Healthcare_India_overvalued_or_undervalued\" title=\"What is the simplest way to summarise Sanofi Consumer Healthcare India overvalued or undervalued?\">What is the simplest way to summarise Sanofi Consumer Healthcare India overvalued or undervalued?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Valuation_Metrics\"><\/span><strong>Sanofi Consumer Healthcare India Overvalued or Undervalued: Valuation Metrics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Valuation Metric<\/th>\n<th>Sanofi Consumer Healthcare India<\/th>\n<\/tr>\n<tr>\n<td>CMP (2 Sep 2026)<\/td>\n<td>Rs 4,092.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 9,491 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>35.68<\/td>\n<\/tr>\n<tr>\n<td>Industry P\/E<\/td>\n<td>51.38<\/td>\n<\/tr>\n<tr>\n<td>P\/B Ratio<\/td>\n<td>27.28<\/td>\n<\/tr>\n<tr>\n<td>Sector Average P\/B (pharmaceutical and consumer health)<\/td>\n<td>7.31<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity (ROE)<\/td>\n<td>76.46%<\/td>\n<\/tr>\n<tr>\n<td>Sector Average ROE (pharmaceutical and consumer health)<\/td>\n<td>12.94%<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 115.50<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 151.07<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.06<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>1.82%<\/td>\n<\/tr>\n<tr>\n<td>Sector Average Dividend Yield (pharmaceutical and consumer health)<\/td>\n<td>0.30%<\/td>\n<\/tr>\n<tr>\n<td>52 Week High \/ Low<\/td>\n<td>Rs 5,357.00 \/ Rs 3,975.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The headline number here is the price to earnings ratio. At 35.68, the Sanofi Consumer Healthcare India PE ratio is 0.69 times the industry average of 51.38. Measured against its pharmaceutical and consumer health sector peers, the gap widens further on other measures too: a P\/B of 27.28 against a sector average of 7.31, and an ROE of 76.46% against a sector average of 12.94%. This table alone is not enough to settle whether Sanofi Consumer Healthcare India overvalued or undervalued is the fair read, but it is the starting point for the rest of this analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Based_on_Its_PE_Ratio\"><\/span><strong>Is Sanofi Consumer Healthcare India Overvalued or Undervalued Based on Its P\/E Ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the P\/E ratio alone, Sanofi Consumer Healthcare India looks undervalued. The stock&#8217;s PE of 35.68 sits well below the industry average of 51.38, which can reflect either a genuine bargain or a market discounting some risk in the business that is not obvious from the ratio itself. Investors relying only on the PE ratio would classify Sanofi Consumer Healthcare India as cheaper than its peers, but the Sanofi Consumer Healthcare India PE ratio still needs to be read alongside its return ratios and earnings quality before calling Sanofi Consumer Healthcare India overvalued or undervalued on this measure alone.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Sanofi Consumer Healthcare India&#8217;s Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_Consumer_Healthcare_Indias_Financial_Growth_and_Profitability\"><\/span><strong>Sanofi Consumer Healthcare India&#8217;s Financial Growth and Profitability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Detailed multi-year revenue and profit figures were not available for Sanofi Consumer Healthcare India at the time of writing, so this section relies on the metrics that are confirmed: a return on equity of 76.46%, an EPS of Rs 115.50, and a book value of Rs 151.07 per share. Readers should treat the Sanofi Consumer Healthcare India overvalued or undervalued call here as based on current ratios rather than a multi-year earnings trend, since a single year of ROE and EPS data is a narrower base to work from than a full revenue and profit history would be. That is worth keeping in mind when weighing how much confidence to place in the current PE of 35.68 relative to the industry average of 51.38.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sanofi Consumer Healthcare India&#8217;s live share price and valuation ratios.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_The_Case_for_Overvalued\"><\/span><strong>Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case for Overvalued<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before getting to the bullet points, it helps to frame the Sanofi Consumer Healthcare India overvalued or undervalued question in terms of what would make the bear case right.<\/p>\n<ul>\n<li><strong>Rich price to book:<\/strong> A P\/B of 27.28 is well above the sector average of 7.31.<\/li>\n<li><strong>Limited margin of safety:<\/strong> At Rs 4,092.00, the stock is only 23.6% below its 52 week high of Rs 5,357.00, leaving less room for error if earnings disappoint.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_The_Case_Against_It\"><\/span><strong>Sanofi Consumer Healthcare India Overvalued or Undervalued: The Case Against It<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The other side of the Sanofi Consumer Healthcare India overvalued or undervalued debate rests on the quality metrics below.<\/p>\n<ul>\n<li><strong>High return on equity:<\/strong> ROE of 76.46% against a sector average of 12.94% reflects efficient use of shareholder capital.<\/li>\n<li><strong>Low leverage:<\/strong> A debt to equity ratio of 0.06 gives Sanofi Consumer Healthcare India a comparatively strong balance sheet.<\/li>\n<li><strong>Reasonable income:<\/strong> A dividend yield of 1.82% offers some cushion while the market decides on the growth story.<\/li>\n<li><strong>52 week range context:<\/strong> At Rs 4,092.00, the stock is 2.9% above its 52 week low of Rs 3,975.00, showing it has already found some support at lower levels.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Verdict_Is_Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_Right_Now\"><\/span><strong>Verdict: Is Sanofi Consumer Healthcare India Overvalued or Undervalued Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On balance, Sanofi Consumer Healthcare India looks undervalued by traditional multiples, trading at a PE of 35.68 against an industry average of 51.38. That gap can close either through the share price catching up or through the business underperforming enough to justify the discount, so the read depends on which explanation fits the company&#8217;s recent earnings trend better. A 76.46% ROE is a reasonable starting point for that judgement, but investors should weigh why the market has kept the stock at a discount before treating the gap as a straightforward opportunity. On the specific question of Sanofi Consumer Healthcare India overvalued or undervalued, the multiples currently point one way even if the fundamentals soften that read.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Could_Change_Whether_Sanofi_Consumer_Healthcare_India_Is_Overvalued_or_Undervalued\"><\/span><strong>What Could Change Whether Sanofi Consumer Healthcare India Is Overvalued or Undervalued?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Two broad scenarios could shift this valuation call on Sanofi Consumer Healthcare India in either direction. On the upside, the market recognising the gap between the PE of 35.68 and the industry average of 51.38, which would show up as the share price re-rating higher without a change in earnings. On the downside, a genuine deterioration in the business that justifies the current discount, in which case the low PE would turn out to be a fair reflection of risk rather than a bargain. Investors watching the Sanofi Consumer Healthcare India share price over the next few quarters should track whether reported ROE holds near 76.46% and whether the PE gap versus the industry average of 51.38 widens or narrows, since both will matter more to the eventual answer on Sanofi Consumer Healthcare India overvalued or undervalued than the current price point on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sanofi Consumer Healthcare India&#8217;s numbers point to a stock that is undervalued on headline multiples, though its return ratios help explain part of the gap. Investors tracking the Sanofi Consumer Healthcare India share price should watch whether earnings growth can keep pace with the current PE of 35.68, since that gap remains the single biggest variable in whether the stock is undervalued, fairly priced, or overvalued from here. For anyone still weighing Sanofi Consumer Healthcare India overvalued or undervalued as a one-line takeaway, the multiples say undervalued while the return ratios offer partial support for the current price. This article is for informational purposes only and is not investment advice.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_Consumer_Healthcare_India_Overvalued_or_Undervalued_FAQs\"><\/span><strong>Sanofi Consumer Healthcare India Overvalued or Undervalued: FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sanofi_Consumer_Healthcare_India_overvalued_or_undervalued_right_now\"><\/span><strong>Is Sanofi Consumer Healthcare India overvalued or undervalued right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Based on a PE ratio of 35.68 against an industry average of 51.38, Sanofi Consumer Healthcare India currently looks undervalued on relative valuation. Its 76.46% ROE is an important part of the Sanofi Consumer Healthcare India overvalued or undervalued picture alongside the PE ratio.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sanofi_Consumer_Healthcare_Indias_current_PE_ratio\"><\/span><strong>What is Sanofi Consumer Healthcare India&#8217;s current PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India&#8217;s price to earnings ratio stands at 35.68, compared with an industry average PE of 51.38. This PE gap is the main input into the Sanofi Consumer Healthcare India overvalued or undervalued call made in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sanofi_Consumer_Healthcare_Indias_return_on_equity\"><\/span><strong>What is Sanofi Consumer Healthcare India&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India generates a return on equity of 76.46%, against a sector average of 12.94% among pharmaceutical and consumer health peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sanofi_Consumer_Healthcare_Indias_52_week_high_and_low\"><\/span><strong>What is Sanofi Consumer Healthcare India&#8217;s 52 week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India&#8217;s 52 week high is Rs 5,357.00 and its 52 week low is Rs 3,975.00. The stock currently trades around Rs 4,092.00, roughly 23.6% below its high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Sanofi_Consumer_Healthcare_India_have_high_debt\"><\/span><strong>Does Sanofi Consumer Healthcare India have high debt?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India carries a debt to equity ratio of 0.06, which is low for its sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sanofi_Consumer_Healthcare_Indias_dividend_yield\"><\/span><strong>What is Sanofi Consumer Healthcare India&#8217;s dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India offers a dividend yield of 1.82% at the current share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sanofi_Consumer_Healthcare_India_a_good_stock_to_buy_at_current_levels\"><\/span><strong>Is Sanofi Consumer Healthcare India a good stock to buy at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India&#8217;s current valuation suits investors who agree with the undervalued read on its PE ratio and are comfortable with the trade-off between its return ratios and its price. This is for informational purposes only and is not investment advice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sanofi_Consumer_Healthcare_Indias_price_to_book_ratio\"><\/span><strong>What is Sanofi Consumer Healthcare India&#8217;s price to book ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sanofi Consumer Healthcare India trades at a price to book ratio of 27.28, compared with a sector average of 7.31 among pharmaceutical and consumer health peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_simplest_way_to_summarise_Sanofi_Consumer_Healthcare_India_overvalued_or_undervalued\"><\/span><strong>What is the simplest way to summarise Sanofi Consumer Healthcare India overvalued or undervalued?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On PE alone, Sanofi Consumer Healthcare India is undervalued against its industry average of 51.38. Layer in the 76.46% ROE and the answer to Sanofi Consumer Healthcare India overvalued or undervalued becomes more nuanced than the headline multiple suggests on its own.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi Consumer Healthcare India trades at a PE of 35.68 versus an industry average of 51.38. We break down its ROE, debt, and valuation ratios to assess if the stock is overvalued or undervalued right now.<\/p>\n","protected":false},"author":36,"featured_media":227989,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-227990","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["227989"],"_edit_lock":["1788342629:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["75"],"rank_math_title":["Sanofi Consumer Healthcare India Overvalued or Undervalued?"],"rank_math_description":["Is Sanofi Consumer Healthcare India overvalued or undervalued right now? A look at its PE ratio, industry PE, ROE and book value versus CMP Rs 4,092.00 to judge the st..."],"rank_math_focus_keyword":["Sanofi Consumer Healthcare India Overvalued or Undervalued"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["41052"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/sanofi-consumer-healthcare-india-overvalued-or-undervalued.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/227990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=227990"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/227990\/revisions"}],"predecessor-version":[{"id":228064,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/227990\/revisions\/228064"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/227989"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=227990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=227990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=227990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}